Rocket Pharma Out Of Orbit, But Ready For Relaunch

Rocket Pharmaceuticals (NASDAQ: RCKT ) is a compelling gene therapy story with two differentiating factors. First, Rocket's therapies seemingly offer a life-long effect as they target cardiovascular and hematology, whereas many gene therapies (especially those targeting liver) display limited durability. Second, theAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or ...